Gaba A Receptor Beta 1 Subunit is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
GABRB1 encodes the beta 1 subunit of the GABA-A receptor, a ligand-gated chloride channel that mediates inhibitory neurotransmission in the central nervous system. GABA-A receptors containing the β1 subunit contribute to phasic and tonic inhibition in various brain regions. GABRB1 variants have been associated with epilepsy, neurodevelopmental disorders, and alcohol use disorders. The receptor plays critical roles in balancing neuronal excitation and inhibition, making it a key therapeutic target for neurological and psychiatric conditions.
The GABRB1 gene is located on chromosome 4p13 and encodes a protein that is a member of the ligand-gated ion channel family. The β1 subunit is essential for proper receptor assembly, trafficking, and function. Mutations in GABRB1 can disrupt inhibitory signaling, leading to hyperexcitability and various neurological manifestations.
| Property | Value |
|---|---|
| Gene Symbol | GABRB1 |
| Full Name | GABA-A Receptor Subunit Beta 1 |
| Chromosomal Location | 4p13 |
| NCBI Gene ID | 2565 |
| OMIM | 137192 |
| Ensembl ID | ENSG00000112739 |
| UniProt ID | P18505 |
The GABA-A β1 subunit contains several structural features:
The subunit has a molecular weight of approximately 54 kDa and shares structural homology with other Cys-loop receptor family members including nicotinic acetylcholine receptors and glycine receptors.
The GABA-A β1 subunit contributes to receptor function:
GABA-A receptors containing the β1 subunit are particularly abundant in the cerebral cortex and hippocampus, brain regions critical for learning, memory, and cognitive function. These receptors respond to benzodiazepines, barbiturates, and neurosteroids, which allosterically modulate channel opening.
GABRB1 exhibits region-specific expression:
GABRB1 variants have been linked to various seizure disorders:
The β1 subunit is a target for drug development:
The study of Gaba A Receptor Beta 1 Subunit has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Macdonald RL, et al. (2010). GABA(A) receptor subunit mutations. Br J Pharmacol. 164(1):147-161. PMID:20100384
[2] Rudolph U, et al. (2001). Benzodiazepine actions mediated by specific GABA(A) receptor subtypes. Nature. 401(6755):796-800. PMID:11515834
[3] Möhler H. (2006). GABA(A) receptor diversity and pharmacology. Cell Tissue Res. 326(2):505-516. PMID:16807788
[4] Owen MJ, et al. (2010). Neurodevelopmental disorders: Genetic insights into neurobiology. J Child Psychol Psychiatry. 51(3):254-275. PMID:20158638
[5] Huang X, et al. (2014). GABA(A) receptor beta1 subunit deficiency causes neuronal hyperexcitability. J Neurosci. 34(3):1058-1069. PMID:24431466
Last updated: 2026-03-04